Trust CO Of Vermont Invitae Corp Transaction History

Trust CO Of Vermont

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$2.13 - $9.01 $852 - $3,604	400 New	400 $1,000
Q1 2022 Apr 05, 2022	SELL	$6.28 - $15.59 $2,512 - $6,236	-400 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$14.7 - $28.67 $5,880 - $11,468	400 New	400 $6,000
Q3 2021 Oct 22, 2021	SELL	$24.31 - $33.6 $9,724 - $13,440	-400 Closed	0 $0
Q1 2018 May 18, 2018	BUY	$4.69 - $10.05 $1,876 - $4,020	400 New	400 $2,000

Q4 2017 Feb 02, 2018	SELL	$7.86 - $9.99 $3,144 - $3,996	-400 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$8.89 - $10.4 $3,556 - $4,160	400	400 $4,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.